Kasimir Marie-Theres, Bialy Jan, Moidl Reinhard, Simon-Kupilik Natascha, Mittlböck Martina, Hiesmayr Michael, Wolner Ernst, Simon Paul
Department of Cardiothoracic and Vascular Anaesthesia and Intensive Care, University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria.
J Heart Valve Dis. 2004 May;13(3):439-43.
EuroSCORE is widely used to assess operative risk. Combined cardiac procedures carry increased perioperative mortality, but the influence of preoperative factors on mid-term outcome is not well known for these patients. The study aim was to determine if EuroSCORE risk influences mid-term survival after combined coronary artery bypass grafting (CABG) and valve surgery.
Follow up (mean 23.7 months) was obtained in 258 consecutive hospital survivors (148 males, 110 females; median age 72.29 years; mean EuroSCORE 7 points) operated on between January 1998 and March 2001. CABG + aortic valve replacement (AVR) was performed in 171 patients, CABG + mitral surgery in 72, and CABG + double valve surgery in 15. Kaplan-Meier estimates were calculated for survival and combined freedom from death and NYHA class III/IV. The Cox regression model was applied to prove the influence of EuroSCORE risk and a number of preoperative and operative variables on mid-term outcome.
Thirty patients (11.63%) died during follow up, and 34 (13.17%) were in NYHA class III/IV. Freedom from death and NYHA class III/IV was 89.3%, 74.7% and 55.2% at 12, 24 and 36 months, respectively. The significant predictor for combined death and NYHA class III/IV was EuroSCORE risk (p = 0.0004). In the subgroup of patients with CABG + mitral valve surgery, age was identified as a significant risk factor for death (p = 0.0346), whereas in the subgroup of patients with CABG + AVR EuroSCORE was detected as significant risk factor for combined death and NYHA class III/IV.
EuroSCORE is an important predictor for poor mid-term outcome after combined CABG and valve surgery.
欧洲心脏手术风险评估系统(EuroSCORE)被广泛用于评估手术风险。心脏联合手术的围手术期死亡率有所增加,但术前因素对这些患者中期预后的影响尚不明确。本研究的目的是确定EuroSCORE风险是否会影响冠状动脉旁路移植术(CABG)和瓣膜手术联合后的中期生存率。
对1998年1月至2001年3月间连续手术的258例住院存活患者(148例男性,110例女性;年龄中位数72.29岁;EuroSCORE平均为7分)进行随访(平均23.7个月)。171例患者接受了CABG + 主动脉瓣置换术(AVR),72例接受了CABG + 二尖瓣手术,15例接受了CABG + 双瓣膜手术。计算Kaplan-Meier生存估计值以及死亡和纽约心脏协会(NYHA)III/IV级联合无事件生存率。应用Cox回归模型来证明EuroSCORE风险以及一些术前和手术变量对中期预后的影响。
随访期间有30例患者(11.63%)死亡,34例(13.17%)处于NYHA III/IV级。12、24和36个月时死亡和NYHA III/IV级联合无事件生存率分别为89.3%、74.7%和55.2%。死亡和NYHA III/IV级联合的显著预测因素是EuroSCORE风险(p = 0.0004)。在CABG + 二尖瓣手术患者亚组中,年龄被确定为死亡的显著危险因素(p = 0.0346),而在CABG + AVR患者亚组中,EuroSCORE被检测为死亡和NYHA III/IV级联合的显著危险因素。
EuroSCORE是CABG和瓣膜手术联合后中期预后不良的重要预测因素。